This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sandoz Ag. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: **Florian Kern: Innovator in Pharmaceutical Formulations**
Introduction
Florian Kern, an accomplished inventor based in Kundl, Austria, has made significant contributions to the field of pharmaceutical formulations. With a strong focus on innovations that enhance the stability and processability of antibiotics, his work is crucial in advancing medical treatments.
Latest Patents
Florian Kern holds one patent titled "Powder mixtures for antibiotic dry syrup formulations." This inventive formulation is uniquely designed as a dry syrup that consists solely of powder mixtures of beta-lactam antibiotics as the active pharmaceutical ingredients, alongside excipients. Remarkably, it can be prepared without any complex processing steps, requiring only simple mixing of dry powder. This innovation provides two essential properties: excellent flowability and high stability against segregation, making it a valuable addition to pharmaceutical technology.
Career Highlights
Florian is currently associated with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His inventive work contributes significantly to the sector, ensuring effective and user-friendly antibiotic formulations that cater to the ever-evolving healthcare landscape.
Collaborations
Throughout his career, Florian Kern has collaborated with notable colleagues, including Stefan Scheler and Johannes Raneburger. These partnerships enhance the collaborative efforts within Sandoz AG, fostering advancements in pharmaceutical research and development.
Conclusion
Florian Kern's innovative approach and dedication to improving antibiotic formulations underscore his role as a pivotal figure in the pharmaceutical industry. His patent reflects a commitment to enhancing drug efficacy and patient outcomes, making him an inspiring inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
